Arcadia Biosciences, Inc. Financial Ratios
RKDA|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-113.1%
Profit Margin
-139.5%
Net Income / Revenue
Asset Turnover
0.77
Revenue / Total Assets
Equity Multiplier
1.05
Total Assets / Equity
Composite: -113.1% (reported: -113.1%)
Profitability
Liquidity
Current Ratio
3.09
Quick Ratio
2.50
Solvency
Interest Coverage
-12.31
Efficiency
Asset Turnover
0.77
Inventory Turnover
2.44
Days Sales Outstanding
-
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
+25.8%
+16.1pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.